Wenzhi Tian | FRP in Health & Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Wenzhi Tian | FRP in Health & Medicine | Best Researcher Award

Doctorate at ImmuneOnco Biopharmaceuticals Shanghai Inc, China

Profile:

Current Position 👨‍💼

Dr. Tian Wenzhi serves as the Chairman of the Board, Chief Executive Officer, Chief Scientific Officer, and Executive Director of his Group. Since founding the company in June 2015, he has led its strategic planning, business management, and research and development efforts. Under his leadership, the Group has emerged as a driving force in biomedical innovation, spearheading projects from discovery to clinical studies. Dr. Tian also oversees subsidiaries like ImmuneTANK, ImmuneOnco Shanghai, Macroimmune, ImmuneOnco Hong Kong, and ImmuneCare.

Publication Achievements 🔖

Dr. Tian’s research contributions have been significant in the biomedical domain, with his work focusing on monoclonal antibody drugs and novel tumor targets. His scientific publications include advancements in B cell functions and breakthroughs in tumor immunology, many of which are widely cited and recognized in international journals. His ability to translate complex research into actionable therapies underscores his contribution to the scientific community.

Ongoing Research 🧬

Dr. Tian’s ongoing research is concentrated on antitumor antibody drugs, autoimmune diseases, and cancer immunotherapy. His innovative approaches involve leveraging cutting-edge bioinformatics tools to identify and validate new drug targets. This ensures precision and effectiveness in therapeutic development, particularly in addressing unmet needs in oncology and immunology.

Research Interests 🌐

Dr. Tian’s research interests encompass a wide array of fields, Cancer Immunotherapy-Developing monoclonal antibodies to target specific tumor pathways. Bioinformatics-Using computational techniques to analyze biological data for drug discovery. Autoimmune Diseases-Investigating the molecular basis and potential therapeutic interventions. CMC Development-Overseeing Chemistry, Manufacturing, and Controls to ensure drug safety and efficacy.

Academic Background 🎓

Dr. Tian’s academic journey began at the Medical School of Zhengzhou University, where he served as a teaching assistant from 1990 to 1993. He later pursued advanced research at Weill Cornell Medical College, focusing on c-Rel regulated genes in B cell functions. This foundational work laid the groundwork for his illustrious career in biomedical research.

Scholarships and Awards 🏆

Dr. Tian’s dedication has earned him prestigious recognitions, Senior Biomedical Engineer Certification by Shanghai Municipal Human Resources and Social Security Bureau (2019). Visiting and distinguished professorships at Zhengzhou University, Henan Medical University, and Fudan University, highlighting his academic and industry leadership.

Bioinformatics Expertise 🔄

Dr. Tian integrates bioinformatics into his research to streamline drug discovery processes. By employing computational tools, he enhances the precision of target selection and validation, contributing to the development of science-driven solutions for complex diseases.

Professional Associations 📚

Dr. Tian actively participates in several biomedical and scientific societies, fostering collaboration and staying at the forefront of emerging trends. His memberships underscore his commitment to advancing global healthcare through research.

Training & Workshops 🏢

Throughout his career, Dr. Tian has organized and participated in numerous international workshops and training sessions, focusing on monoclonal antibody development, clinical studies, and advanced manufacturing techniques. These initiatives have enriched his expertise and disseminated knowledge across the industry.

Oral Presentations📈

Dr. Tian has delivered impactful presentations at prestigious conferences worldwide, Innovative approaches to antibody drug development. The role of c-Rel genes in immune regulation. Strategies for effective clinical trial management.

Tasks Completed as a Researcher 🔄

Dr. Tian’s career is marked by significant achievements, Establishing a robust pipeline for antitumor drug discovery. Cloning and studying critical genes involved in B cell function. Leading CMC development and ensuring regulatory compliance. Overseeing multiple clinical studies that advance therapeutic applications.

Success Factors 🌟

Dr. Tian attributes his success to a combination of visionary leadership, a science-driven approach, and collaborative partnerships. His ability to bridge the gap between academic research and clinical application has been instrumental in his Group’s success.

Laboratory Experience 🔧

Dr. Tian’s extensive laboratory experience spans over three decades. From cloning genes at Weill Cornell Medical College to leading monoclonal antibody research at ImClone Systems, his hands-on expertise has shaped cutting-edge therapies. His publications, often resulting from meticulous lab work, are testaments to his enduring contribution to biomedical science.

Conclusion 🖖

Dr. Tian Wenzhi’s illustrious career is a testament to his unwavering commitment to biomedical innovation. From pioneering research to fostering global collaborations, his work continues to make a profound impact on healthcare and science. Through his leadership, vision, and dedication, Dr. Tian exemplifies the transformative power of scientific discovery.

📖Publications:

Paper Title: Development of bioassay platforms for biopharmaceuticals using Jurkat-CAR cells by AICD

  • Authors: Chen, D.; Li, S.; Yang, Y.; Zhang, R.; Tian, W.
  • Journal: Journal of Pharmaceutical and Biomedical Analysis
  • Year: 2024

Paper Title: IMM2520, a novel anti-CD47/PD-L1 bispecific antibody for cancer immune therapy

  • Authors: Yang, C.; Li, S.; Chen, D.; Tu, X.; Tian, W.
  • Journal: Heliyon
  • Year: 2024

Paper Title: Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy

  • Authors: Zhang, B.; Shi, J.; Shi, X.; Xu, L.; Li, W.
  • Journal: Drug Resistance Updates
  • Year: 2024

Paper Title: Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions

  • Authors: Li, X.; Tian, W.; Jiang, Z.; Leng, X.; Yu, J.
  • Journal: Cancer Immunology, Immunotherapy
  • Year: 2024

Paper Title: DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathways

  • Authors: Liu, L.; Gong, D.; Sun, H.; An, G.; Hao, M.
  • Journal: Frontiers in Immunology
  • Year: 2024

 

Joon myong Song | Composite Materials Science | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Joon myong Song | Composite Materials Science | Best Researcher Award

Doctorate at Seoul National University, College of Pharmacy, South Korea

Profiles:

📝Introduction

Prof. Joon Myong Song, Ph.D., is a distinguished figure in the realm of cancer research and nanomedicine. Serving as the Director of the Anticancer Immune Cell Research Center at the College of Pharmacy, Seoul National University, South Korea, he has made significant strides in developing innovative cancer therapies and drug delivery systems.

🎓Academic Journey 

Prof. Song’s academic journey began at Sogang University, Seoul, Korea, where he earned his BS and MS in Chemistry in 1991 and 1993, respectively. His quest for knowledge led him to Kyushu University in Japan, where he completed his Ph.D. in Molecular Science and Technology in 1997.

🏛️Professional Experience 

Prof. Song’s career in research began as a Research Associate at Iowa State University (1998-2000) and Oak Ridge National Laboratory (2000-2003). He then transitioned to academia as an Assistant Professor at Chungnam National University (2004-2005). In 2005, he joined the College of Pharmacy at Seoul National University, where he ascended through the ranks, becoming a full Professor in 2013. His global expertise was further enriched during his tenure as a Visiting Scientist at the University of Utah in 2011-2012.

📚Editorial Roles 

Prof. Song’s expertise is recognized in the scientific community, where he serves as an Associate Editor for Nano Convergence and a member of the Editorial Board for Chemosensors since 2020.

🔬Research Interests 

Prof. Song’s research is at the intersection of cancer therapy, nanotechnology, and drug delivery systems. His pioneering work includes:

  • X-Clarity: Transparent Tumor Imaging: Developing transparent tumor imaging techniques to enhance drug delivery systems in challenging tumor microenvironments.
  • Synthesis of Therapeutic Agents: Creating anti-inflammatory, anticancer, and antidiabetic agents, including ruthenium-based compounds and insulin-mimetic vanadyl-Schiff base complexes.
  • 3D Bioprinting: Innovating bioassays with spheroids and studying cardiotoxicity using cardiac tissue models.

📜Contributions to Science 

With 140 publications in prestigious SCI(E) journals, Prof. Song has made substantial contributions to various fields, including oncology, nanotechnology, and pharmacology. His research has been widely recognized, with notable works such as transparent tumor imaging and innovative drug delivery systems.

🌐Professional Memberships 

Prof. Song is an active member of several esteemed scientific societies, including the Korean Biochip Society, the Korean Society of Analytical Sciences, the Korean Pharmaceutical Society, the Korean Chemical Society, and the American Chemical Society. His leadership is highlighted by his role as the President of the Korean Biochip Society in 2023.

📖Publications:

Paper Title: Striking hypoxic cancer cell killing effect of a tumor-responsive nanodrug carrier in tumor microenvironment

  • Authors: Hong, S., Balwe, S.G., Samson, A.A.S., Song, J.M.
  • Journal: Nano Today
  • Year: 2024

Paper Title: GRP78 blockade overcomes acquired resistance to EGFR-tyrosine kinase inhibitors in non-small cell lung cancer

  • Authors: Park, J., Purushothaman, B., Hong, S., Song, J.M., Kang, K.W.
  • Journal: Life Sciences
  • Year: 2024

Paper Title: High-Resolution In Situ High-Content Imaging of 3D-Bioprinted Single Breast Cancer Spheroids for Advanced Quantification of Benzo(a)pyrene Carcinogen-Induced Breast Cancer Stem Cells

  • Authors: Hong, S., Song, J.M.
  • Journal: ACS Applied Materials and Interfaces
  • Year: 2023

Paper Title: Verification of Nanomaterial-Induced Size-Dependent Human Etherà-Go-Go-Related Gene Potassium Channel Blockage Using Three-Dimensional Bioengineered Functional Cardiac Tissue Constructs

  • Authors: Samson, A.A.S., Balwe, S.G., Hong, S., Song, J.M.
  • Journal: Chemistry of Materials
  • Year: 2023

Paper Title: Drug delivery in transarterial chemoembolization of hepatocellular carcinoma: Ex vivo evaluation using transparent tissue imaging

  • Authors: Hong, S., Choi, W.S., Purushothaman, B., Song, J.M., Choi, J.W.
  • Journal: Acta Biomaterialia
  • Year: 2022

 

HongYuan Qi | Failure Analysis and Damage Mechanics | Best Researcher Award

Posted on by ScienceFather

Prof. HongYuan Qi | Failure Analysis and Damage Mechanics | Best Researcher Award

School of Mechanical, Electronic and Control Engineering, Beijing Jiaotong University – China

Professional Profiles:

 

🛠️ Professor Hongyuan Qi: A Pioneer in Mechanical Engineering and Acoustic Emission Technology 🚆

Early Academic Pursuits 📚

Hongyuan Qi’s academic journey began at the Northeast Heavy Machinery Institute, where he earned his Bachelor’s degree in Machinery Manufacturing Equipment and Technology in 1989. His passion for engineering led him to pursue a Master’s degree in Metallurgical Machinery at the same institution, completing it in 1995. Qi’s dedication to academic excellence continued at Yanshan University, where he received his PhD in Mechanical Design and Theory in 2000. These foundational years equipped him with the knowledge and skills that would later define his illustrious career.

Professional Endeavors 💼

Following his PhD, Qi undertook postdoctoral research at Beijing Jiaotong University from March 2000 to May 2002. This period marked the beginning of a long and fruitful association with the institution. In June 2002, he joined the Department of Measurement and Control as an Associate Professor in the School of Mechanical, Electronic, and Control Engineering. Over two decades, he significantly contributed to the department’s research and academic reputation, earning a promotion to Professor in January 2023.

Before his tenure at Beijing Jiaotong University, Qi gained valuable industry experience as an Engineer at Tianjin Heavy Machinery Plant Institute from August 1989 to August 1992. This role provided practical insights that complemented his academic expertise, fostering a well-rounded approach to engineering challenges.

Research and Innovations 🧪

Professor Qi’s research primarily focuses on the health monitoring and intelligent operation of high-speed train components. His innovative work in prognostics and health management technology for rail transit equipment has led to significant advancements. Notable projects include the health monitoring of EMU gearboxes based on acoustic emission technology (Project Number M19L01500), completed in October 2023, and the component fatigue crack detection technology based on acoustic emission (Project Number M13L00420), completed in October 2015.

Currently, Qi is leading research on crack detection technology of axle brake bands (Project Number M16L00480) and analyzing techniques for next-generation weapon systems (Project Number M20GY1400010). These projects showcase his continuous commitment to advancing safety and efficiency in mechanical systems.

Accolades and Recognition 🏅

Qi’s contributions have been widely recognized through various publications and awards. He has authored and co-authored numerous research papers in prestigious journals, including “Structural Health Monitoring-An International Journal” and “Mathematics and Mechanics of Solids.” His work on a novel acoustic emission sensor for monitoring high-speed train bearings highlights his innovative approach to engineering challenges.

His educational contributions are equally significant, with notable publications such as “Fundament of Control Theory” and “MATLAB Language and Practice Tutorial.” These books have become essential resources for engineering students and professionals alike.

Impact and Influence 🌍

Professor Qi’s research has a profound impact on both academia and industry. His work on acoustic emission technology not only advances academic knowledge but also offers practical solutions for real-world applications. His research has directly contributed to the safety and reliability of rail transit systems, making a tangible difference in the field.

With a total citation count of 107, Qi’s influence extends across the academic community, reflecting the relevance and significance of his work. His dedication to mentoring students and leading innovative research projects continues to inspire future generations of engineers.

Legacy and Future Contributions 🌟

Looking ahead, Professor Qi’s legacy will undoubtedly continue to shape the future of mechanical engineering. His pioneering research and practical applications set a high standard for excellence in the field. As he continues to explore new frontiers in health monitoring and intelligent systems, his contributions will leave an enduring mark on mechanical engineering and beyond.

Professor Hongyuan Qi’s journey from a dedicated student to a respected professor and researcher exemplifies his unwavering commitment to mechanical engineering. His work not only advances knowledge but also provides practical solutions that enhance the safety and efficiency of mechanical systems, ensuring a lasting legacy in the field.

Publication Top Noted:

Marat Gafurov | Composite Materials Science | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Marat Gafurov | Composite Materials Science | Best Researcher Award

Institute of Physics/ Kazan Federal University, Kazan, Russia

Professional Profiles:

🌟 Marat Gafurov: Renowned Physicist and Leader in Condensed Matter Physics 🌟

Early Academic Pursuits🌍 

Marat Gafurov was born on August 23, 1972, in Kazan, Russian Federation. His academic journey in physics began at Kazan State University (KSU), where he earned his diploma with honors in physics and electronics in 1994. He continued his studies at KSU, completing his Ph.D. in Physics in 1997. His doctoral research focused on the magnetic properties of impurity ions and intrinsic magnetic centers in high-temperature compounds, laying the groundwork for his future endeavors in condensed matter physics.

Professional Endeavors🏅

Gafurov’s professional career at Kazan Federal University (KFU), previously Kazan State University (KGU), began in 1999. Over the years, he has held various positions, from Design Technician to Senior and Leading Researcher. His expertise and dedication to the field earned him a position as an Associate Professor and later a Professor in the Department of Medical Physics at KFU. In December 2020, Gafurov became the Deputy Director of the Institute of Physics for scientific activities and was subsequently appointed as the Director in October 2021.

Contributions and Research Focus📚🧪

Gafurov’s research is centered on the development and application of magnetic resonance methods for studying liquids, solids, and biological objects. His work has significantly advanced the understanding of electron paramagnetic resonance (EPR) and double electron-nuclear resonance (ENDOR) in various materials, including liquids and oil-dispersed systems. He has also contributed to the development of equipment for high-field experiments on dynamic nuclear polarization for biological applications, during his postdoctoral fellowship at Goethe University in Frankfurt, Germany.

Accolades and Recognition🏆

Marat Gafurov’s contributions to science and education have been widely recognized. He has received numerous accolades, including the Badge “For Merit in Education” from the Ministry of Education and Science of the Republic of Tatarstan in 2023. Additionally, he has been awarded multiple diplomas from the rector and administration of KFU for his excellence in scientific and teaching activities, as well as a diploma from the Administration of the Executive Committee of Kazan for his scientific achievements.

Impact and Influence👨‍🏫

Gafurov’s impact extends beyond his research contributions. He has supervised over 40 final qualifying works (bachelor’s, master’s, and Ph.D.) in various fields, including physics, electronics, and medical physics. Currently, he supervises two Ph.D. students, one master’s student, and two bachelor’s students. His role as an expert for the Russian Academy of Sciences (RAS), the Russian Science Foundation (RSF), and other prestigious organizations highlights his influence in the scientific community.

Legacy and Future Contributions🚀

Marat Gafurov’s legacy is defined by his dedication to advancing scientific knowledge and fostering academic growth. As the head of multiple interdisciplinary research projects and grants at KFU, he continues to push the boundaries of condensed matter physics and its applications in medical and biological fields. His ongoing projects, such as the development of biocompatible materials for bone tissue diseases and the creation of modern experimental stations for synchrotron and neutron research, underscore his commitment to innovation and excellence.

Publication Top Noted: